Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis
Condition(s):Chronic HCV InfectionLast Updated:October 1, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Chronic HCV InfectionLast Updated:October 1, 2020Completed
Condition(s):Chronic HCV HepatitisLast Updated:February 22, 2023Completed
Condition(s):Diffuse Large B Cell LymphomaLast Updated:July 11, 2023Recruiting
Condition(s):Treatment-naїve Mantle Cell LymphomaLast Updated:October 12, 2022Recruiting
Condition(s):Hormone Treatment-naïve Participants With Prostate CancerLast Updated:November 19, 2018Completed
Condition(s):Treatment-naive Advanced Non-small Cell Lung CancerLast Updated:February 1, 2023Completed
Condition(s):Follicular Lymphoma; Small Lymphocytic LymphomaLast Updated:July 24, 2023Terminated
Condition(s):Genotype 1 Chronic Hepatitis CLast Updated:January 30, 2015Completed
Condition(s):Chronic Hepatitis c Genotype 1Last Updated:October 31, 2022Completed
Condition(s):Patients With Advanced Treatment Naive LCNECLast Updated:March 2, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.